Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
NetSol Technologies Inc is a software-application business based in the US. NetSol Technologies shares (NTWK) are listed on the NASDAQ and all prices are listed in US Dollars. NetSol Technologies employs 1,447 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$4.57|
|52-week range||$2.35 - $5.30|
|50-day moving average||$4.29|
|200-day moving average||$4.44|
|Wall St. target price||$8.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.15|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-20)||0.22%|
|1 month (2021-09-27)||17.78%|
|3 months (2021-07-27)||6.53%|
|6 months (2021-04-27)||-15.37%|
|1 year (2020-10-26)||77.82%|
|2 years (2019-10-25)||-10.22%|
|3 years (2018-10-26)||8.4|
|5 years (2016-10-26)||6.3|
Valuing NetSol Technologies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of NetSol Technologies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
NetSol Technologies's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 31x. In other words, NetSol Technologies shares trade at around 31x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
NetSol Technologies's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.3514. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into NetSol Technologies's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
NetSol Technologies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $6.7 million.
The EBITDA is a measure of a NetSol Technologies's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$54.9 million|
|Operating margin TTM||4.95%|
|Gross profit TTM||$29.3 million|
|Return on assets TTM||1.94%|
|Return on equity TTM||3.55%|
|Market capitalisation||$52.4 million|
TTM: trailing 12 months
There are currently 110,894 NetSol Technologies shares held short by investors – that's known as NetSol Technologies's "short interest". This figure is 1.2% up from 109,561 last month.
There are a few different ways that this level of interest in shorting NetSol Technologies shares can be evaluated.
NetSol Technologies's "short interest ratio" (SIR) is the quantity of NetSol Technologies shares currently shorted divided by the average quantity of NetSol Technologies shares traded daily (recently around 17828.617363344). NetSol Technologies's SIR currently stands at 6.22. In other words for every 100,000 NetSol Technologies shares traded daily on the market, roughly 6220 shares are currently held short.
However NetSol Technologies's short interest can also be evaluated against the total number of NetSol Technologies shares, or, against the total number of tradable NetSol Technologies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case NetSol Technologies's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 NetSol Technologies shares in existence, roughly 10 shares are currently held short) or 0.0114% of the tradable shares (for every 100,000 tradable NetSol Technologies shares, roughly 11 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against NetSol Technologies.
Find out more about how you can short NetSol Technologies stock.
We're not expecting NetSol Technologies to pay a dividend over the next 12 months.
NetSol Technologies's shares were split on a 1:10 basis on 12 August 2012. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your NetSol Technologies shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for NetSol Technologies shares which in turn could have impacted NetSol Technologies's share price.
Over the last 12 months, NetSol Technologies's shares have ranged in value from as little as $2.35 up to $5.3. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NetSol Technologies's is 0.872. This would suggest that NetSol Technologies's shares are less volatile than average (for this exchange).
NetSol Technologies, Inc. designs, develops, markets, and exports software products to the automobile financing and leasing, banking, and financial services industries worldwide. The company offers NFS Ascent, a suite of financial applications for businesses in the finance and leasing industry. Its NFS Ascent constituent applications include Omni Point of Sale, a web-based application; Contract Management System (CMS), an application for managing and maintaining credit contracts; Wholesale Finance System (WFS), a system for automating and managing the lifecycle of wholesale finance; Dealer Auditor Access System, a web-based solution that could be used in conjunction with WFS or any third-party wholesale finance system; NFS Ascent On The Cloud, a cloud-version of NFS Ascent; and NFS Digital solutions covering Self Point of Sale, Mobile Account, Mobile Point of Sale, Mobile Dealer, Mobile Auditor, Mobile Collector, and Mobile Field Investigator. The company also provides Otoz Digital Auto-Retail, a white-labelled SaaS platform; Otoz Ecosystem, an API-based architecture; and Otoz Platform, a white label platform, which includes Dealer Tool and Customer App portals. In addition, it offers system integration, consulting, and IT products and services. It serves blue chip organizations, Dow-Jones 30 Industrials, Fortune 500 manufacturers and financial institutions, vehicle manufacturers, and enterprise technology providers.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.